Sangamo BioSciences (SGMO -8.3%) slides after presenting new data from its program to develop a...

|About: Sangamo BioSciences, Inc. (SGMO)|By:, SA News Editor

Sangamo BioSciences (SGMO -8.3%) slides after presenting new data from its program to develop a functional cure for HIV/AIDS in two presentations at the 20th Conference on Retroviruses and Opportunistic Infections. SGMO expects to present preliminary data in the first half of 2013 and the full data set from both trials by the end of 2013.